In May 2026, At the EASL Congress 2026, MetaVia presented promising late-breaking Phase 1 clinical trial results for DA-1726, an investigational dual GLP-1 and glucagon receptor agonist under development for obesity and Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Shi A, et al
BPC-157 Dosage Calculator BPC-157 is a peptide known for its powerful healing and recovery properties
To restore antioxidant capacity, the reduced form of coenzyme Q 10 , ubiquinol (CoQ 10 H 2 ), regenerates -TOH by donating electrons, producing either the semiquinone radical (CoQ 10 H) or the fully oxidized form, ubiquinone (CoQ 10 )
Before long, more than 10 different companies had applied to Chinas Center for Drug Evaluation to manufacture semaglutide
When selecting an anticoagulant, healthcare providers should understand the pharmacokinetics, potential side effects, and contraindications